Canadian drug firm moving to greater Charleston SC, to SC's first gigabit community in Summerville

In the spring, Aeterna Zentaris announced the transfer of its library of 100,000 drug compounds to the Medical University of South Carolina in a collaborative venture it hopes will lead to new treatments.

MUSC can make that available to researchers within the University of South Carolina system. It also will own any therapeutic compounds it discovers outside of the company’s areas of interest.

Under the agreement, MUSC will try to provide Aeterna Zentaris with at least 10 development candidates over 10 years starting in 2018. The company also will get the rights to license any of those ideas.

Read it all from the local paper.

Posted in * Culture-Watch, * Economics, Politics, * International News & Commentary, * South Carolina, America/U.S.A., Canada, Consumer/consumer spending, Corporations/Corporate Life, Economy, Science & Technology